Form D · Pharmaceuticals

X4 Pharmaceuticals, Inc.

Cambridge, MA · CIK 0001632304

Offering snapshot reported Sep 21, 2018 · SEC filing

Reported sold
$35M
Offering amount: $35M
Investors reported
214
Form D · investor count
Minimum accepted
$50K
Reported outside-investor minimum
First sale
Nov 1, 2017
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$17.5M$35MNov 15, 2017: $25,838,812.00Nov 15, 2017Sep 21, 2018: $34,999,150.00Sep 21, 2018

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$25,838,812 → $34,999,150
  • Reported investors213 → 214

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 21, 2018Amendment$34,999,150$9,160,338vs Nov 15, 2017214SEC filing
Nov 15, 2017Initial$25,838,812No comparison213SEC filing
Aug 28, 2015Initial$37,499,999No comparison220SEC filing
Jan 30, 2015Initial$735,000No comparison11SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$2.37M (estimated)
Finders' fees
$0
Form D file number
021-298854

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
Maxim Group, LLC120708

Source: Form D, filed Sep 21, 2018. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert Arbeit Executive
Isaac Blech Director
John Celebi Executive
John Cheney Executive
Andrea K. Franz Executive
Michael Gilman Director
Alison Lawton Executive
Nancy Lurker Director
Adam Mostafa Executive
Sudha Parasuraman Executive
Paula Ragan Director, Executive
Alan E. Walts Director, Executive
Michael Wyzga Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
955 Massachusetts Avenue
Cambridge, MA, 02139